/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749545033&Signature=NIyASh~ciG74AXtomQPX4W6koiTRJ1rg5hj3TCdXuMvzzuAIgzfkAZG1skV3VOsjR0Gmh0qW4QpoD4-UJp-QH49gkvPcfA~RGV6SY9BRDmRGBC0XCLOyFDZbb4Vsnb4ol2mxwjRqUSVKj1I6fc8D-DFREfoV77Qxudd4p1Uk-6rWwM6Vy71viDFGU-uGs5oOZuQs2Jit0cVZfY3uvXlNTxW7Wer2QsN2T0ipq~k2WDfAH7DLyXPZvhgQt5KzJAsiPY2vivnsn-aQiHclfYsYzj2BG968f1O5f4zx2SppE7qDQTdxRHD8B6OdyQ1aowMkdoUha50RoEMWICYfQm25Hg__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
Diamyd Medical AB (publ)
DMYD | FN
Overview
Corporate Details
- ISIN(s):
- SE0005162872 (+5 more)
- LEI:
- 5493003NP2HNQDEKB804
- Country:
- Sweden
- Address:
- BOX 7349, 103 90 STOCKHOLM
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Diamyd Medical AB is a biotech company working on precision medicine for autoimmune diabetes. They are developing antigen-specific immunotherapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
BSF ENTERPRISE PLC | United Kingdom | BSFA | |
|
Can-Fite BioPharma Ltd. | Israel | CANF | |
|
Cantargia | Sweden | CANTA | |
|
Captor Therapeutics S.A. | Poland | CTX | |
|
Carbiotix AB | Sweden | CRBX | |
|
Cellectis | France | ALCLS | |
|
CELLULAR GOODS PLC | United Kingdom | CBX | |
|
Celyad Oncology SA | Belgium | CYAD | |
|
Cereno Scientific AB | Sweden | CRNO | |
|
Cessatech A/S | Denmark | CESSA |